QuantalX Neuroscience
1 known investors
Find your way into QuantalX Neuroscience
Sign up to see every warm intro you have to QuantalX Neuroscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the QuantalX Neuroscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
QuantalX develops Delphi-MD, a medical device that uses controlled TMS stimulation to record TMS-evoked potentials across cortical networks and provide neurologists with quantitative data on brain-network function. It is used to differentiate overlapping neurological conditions, track neurodegenerative disease progression, and assess treatment response at the point of care.
Investors · 1
Frequently asked questions
- What does QuantalX Neuroscience do?
- QuantalX develops Delphi-MD, a medical device that uses controlled TMS stimulation to record TMS-evoked potentials across cortical networks and provide neurologists with quantitative data on brain-network function. It is used to differentiate overlapping neurological conditions, track neurodegenerative disease progression, and assess treatment response at the point of care.
- Who are QuantalX Neuroscience's investors?
- QuantalX Neuroscience's investors include EMV Capital.
